Peritoneal metastasis in gastric cancer arises when tumour cells detach from the primary gastric lesion, survive in the ascitic fluid and adhere to the peritoneal lining. Key steps include loss of ...
This manuscript reports the results of the Indian Network for Development of Peritoneal Surface Oncology and Indian Society of Peritoneal Surface Malignancies (INDEPSO-ISPSM) consensus that aimed to ...
New study and promising results from the first clinical trial in patients provide novel insights and new hope for one of the deadliest of cancers. Gastric cancer remains a formidable adversary, ...
Metastatic colorectal adenocarcinoma (mCRC) with proficient mismatch repair (pMMR) is associated with poor response to cytotoxic chemotherapy in the refractory setting. In patients with peritoneal ...
Neoantigen (tumor-specific antigen) mRNA-based vaccines induce progenitor‑exhausted T cells that support anti‑PD‑1 therapy, leading to enhanced antitumor efficacy against gastric cancer, which has ...
Gastric cancer remains a formidable adversary, ranking as the fifth most common cancer and the third-leading cause of cancer-related deaths worldwide, with over 1,000,000 new cases and close to ...
Preclinical research showed that ascites may actively protect metastatic ovarian cancer against ferroptosis and help drive ...
Peritoneal mesothelioma is a cancer that develops in the membrane that lines the abdomen and its organs, known as the peritoneum. Asbestos exposure is its most common risk factor. Peritoneal ...
Researchers from National University Hospital (NUH), National Cancer Institute, Singapore (NCIS), the Yong Loo Lin School of Medicine, National University of Singapore, Duke-NUS Medical School and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results